Title:
新規な2-アミノピリミジノン誘導体およびそれらの使用
Document Type and Number:
Japanese Patent JP2009515949
Kind Code:
A
Abstract:
This invention relates to novel compounds having the structural formula I below: (I) and to their pharmaceutically acceptable salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
More Like This:
WO/2016/016366 | SUBSTITUTED DIHYDROPYRIMIDINONES AND THEIR USE AS INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY |
WO/2015/128307 | ETHYNYL DERIVATIVES |
WO/2001/083427 | PPAR$g(g) MODULATORS |
Inventors:
Jeffrey Albert
Donald Andisik
Phil Edwards
Mark Sylvester
Donald Andisik
Phil Edwards
Mark Sylvester
Application Number:
JP2008541107A
Publication Date:
April 16, 2009
Filing Date:
November 13, 2006
Export Citation:
Assignee:
ASTRAZENECA AKTIEBOLAG
ASTEX THERAPEUTICS LIMITED
ASTEX THERAPEUTICS LIMITED
International Classes:
C07D239/22; A61K31/513; A61K31/517; A61P25/14; A61P25/16; A61P25/28; A61P43/00; C07D239/47; C07D239/95; C07D405/10
Attorney, Agent or Firm:
Junji Yuda
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi
Shoji Miwa
Noriyuki Takebayashi
Chika Takagi